Loading data
FBIONasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 63.26 m USD | 57.68 m USD | 84.51 m USD | 75.74 m USD | 68.79 m USD |
| Cost of revenue | 20.92 m USD | 20.88 m USD | 22.89 m USD | 30.78 m USD | 32.08 m USD |
| Research and development expense | — | — | 106.07 m USD | 134.88 m USD | 128.87 m USD |
| Selling, general and administrative expense | 96.4 m USD | 87.73 m USD | 90.98 m USD | 113.66 m USD | 86.84 m USD |
| Operating profit | -70.22 m USD | -110.38 m USD | -142.34 m USD | -203.56 m USD | -188.54 m USD |
| Profit before tax | -33.54 m USD | -120.54 m USD | -153.63 m USD | -213.46 m USD | -164.35 m USD |
| Income tax expense | -600 k USD | 312 k USD | 500 k USD | 449 k USD | 500 k USD |
| Net income (reported basis) | 37 m USD | 21 m USD | 31 m USD | -214 m USD | -64.7 m USD |
| Net income attributable to common shareholders | -1.88 m USD | -55.89 m USD | -68.67 m USD | -94.61 m USD | — |
| Basic earnings per share | -0.07 USD/share | -2.69 USD/share | -8.47 USD/share | -15.97 USD/share | -0.79 USD/share |
| Diluted earnings per share | -0.07 USD/share | -2.69 USD/share | -8.47 USD/share | -15.97 USD/share | -0.79 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.